A Study of Skipping Radiation Therapy in People With Breast Cancer

Full Title

SuperHERO: A Phase II Trial Evaluating Radiotherapy Omission for Low-risk HER2-positive Breast Cancer

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Lior Braunstein’s office at 201-775-7446. 

Protocol
26-385
Investigator
Co-Investigators
Diseases
ClinicalTrials.gov ID
NCT07895511